|
| Status |
Public on Sep 23, 2021 |
| Title |
Hepatitis C virus scarring of the epigenome and creates targetable vulnerabilities following viral clearance |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Methylation profiling by genome tiling array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34387871 |
| Submission date |
Mar 03, 2021 |
| Last update date |
Dec 23, 2021 |
| Contact name |
Keith D Robertson |
| E-mail(s) |
robertson.keith@mayo.edu
|
| Phone |
507-266-4886
|
| Organization name |
Mayo Clinic
|
| Department |
Molecular Pharmacology & Experimental Therapeutics
|
| Lab |
Epigenetic Etiology of Human Disease Laboratory
|
| Street address |
200 First Street SW, Stabile 12-70
|
| City |
Rochester |
| State/province |
MN |
| ZIP/Postal code |
55905 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
| GPL21145 |
Infinium MethylationEPIC |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (83)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE168178 |
Clearance of chronic hepatitis C virus infection leaves scars on the epigenome driven by an interferon response and creates targetable vulnerabilities [seq] |
| GSE168185 |
Interferon drives hepatitis C virus scarring of the epigenome and creates targetable vulnerabilities following viral clearance [array] |
|
| Relations |
| BioProject |
PRJNA706410 |
Less...
More...